2m 2m 2m 2m 2m 2m 2m
EXAGEN (XGN)
NASDAQ
$5.02-$0.02 (-0.30%)
Price as of Nov 12, 2026 9:42 AM EST- $122.0MMarket Cap
- -47.50%1-Year Change
- Diagnostics & ResearchIndustry
EXAGEN (XGN)
$5.02-$0.02 (-0.30%)
XGN | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $5.04 | ||
Change | -$0.22 (-4.28%) | ||
Open | $5.59 | ||
High | $5.65 | ||
Low | $4.69 | ||
Previous Close | $5.26 | ||
Volume | 1,201,445 | ||
30-Day Average Volume | 519,335 | ||
1-Week Change | -40.83% | ||
1-Month Change | -40.20% | ||
1-Year Change | -47.50% | ||
3-Year Change | 247.24% | ||
5-Year Change | -64.09% | ||
Fundamentals | |||
Shares Outstanding | 24.2M | ||
Total Assets | $55.4M | ||
Market Cap | $122.0M | ||
Enterprise Value | $116.7M | ||
Period: QTR TTM FY | |||
Revenue | $18.4M | ||
Net Income | -$6.3M | ||
Free Cash Flow | -$2.8M | ||
EBIT | -$5.2M | ||
EBITDA | -$4.6M | ||
Net Working Capital | $32.2M | ||
EPS | -$0.25 | ||
Enterprise Value/EBITDA | -25 | ||
Enterprise Value/Revenue | 6 | ||
P/B | 9 | ||
P/E | -20 | ||
PEG | 0 | ||
Price/Free Cash Flow | -44 | ||
Price/Operating Cash Flow | -47 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue